Populations receiving GLP-1 RAs may be at a higher risk of colorectal cancer due to multiple factors, such as insulin resistance, chronic inflammation, and obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.